It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
BACKGROUND: Paravalvular leak (PVL) has significant impact on long-term outcomes in patients after transcatheter aortic valve implantation (TAVI). This study sought to determine whether multi-slice computed tomography (MSCT)-guided valve selection reduces PVL after CoreValve implantation.
METHODS: The analysis encompassed 69 patients implanted with CoreValve and were divided into two groups. In Group I (30 patients), valve selection was based on standard procedures, in Group II (39 patients), on MSCT measurements. Paravalvular leak was assessed with angiography and echocardiography.
RESULTS: Multi-slice computed tomography results influenced a change of decision as to the size of the implanted valve in 12 (30.9%) patients in Group II and would have caused the decision to change in 9 (37.5%) patients in Group I. The degree of oversizing in Group I and II was 12.8% ± ± 7.6% vs. 18.6% ± 5.1% (p = 0.0006), respectively. The oversizing among the patients with leak degree of 0–1 and ≥ 2 was 18.1% ± 6.0% and 12.8% ± 7.4% (p = 0.0036). Angiographic assessment indicated post-procedural PVL ≥ 2 in 50% of patients in Group I and 20.5% in Group II (p = 0.01), while echocardiographic assessment indicated the same in 73.3% of patients in Group I and 45.6% in Group II (p = 0.0136). The composite endpoint occurred in 26.6% (8/30) patients in Group I vs. 5.1% (2/39) patients in Group II (p = 0.0118).
CONCLUSIONS: Selecting the CoreValve device based on MSCT resulted in smaller rates of PVL and less frequent composite endpoint. In 1/3 of patients MSCT led to a change of the valve size. The degree of oversizing had a significant impact on PVL.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Department of Cardiology, Silesian Center for Heart Diseases, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia, Zabrze, Poland. [email protected]
2 Silesian Center for Heart Diseases, 3rd Department of Cardiology, Medical University of Silesia,
3 Silesian Center for Heart Diseases, Department of Cardiac Surgery and Transplantology, Medical University of Silesia,
4 Silesian Center for Heart Diseases, Diagnostic Department, Department of Radiology, Medical University of Silesia,
5 Silesian Center for Heart Diseases, Department of Cardiology, Congenital Heart Diseases and Electrotherapy. Medical University of Silesia.
6 Silesian Center for Heart Diseases, Department of Cardiology, Congenital Heart Diseases and Electrotherapy
7 Silesian Center for Heart Diseases, Department of Cardiac Surgery and Transplantology
8 Silesian Center for Heart Diseases, 3rd Department of Cardiology
9 Students Scientific Society, Medical University of Silesia
10 Silesian Center for Heart Diseases, Department of Cardiac Surgery and Transplantology, Medical University of Silesia
11 Silesian Center for Heart Diseases, Department of Cardiology, Congenital Heart Diseases and Electrotherapy. Medical University of Silesia